It's ugly out there, but the company's well-girded.

This isn't the Apple I've come to know and love.

Only in one rare instance.

You can't ignore these stocks right now.

But it's a change with delayed payoff.

Merck and Sanofi rekindle their animal love.

A Fool peers in through Wall Street's out door.

Yes. And that's just the start of the good news.

China's real estate market is still blazing.

You've got to love biotech.

Satellite radio has been on fire over the past year, but your portfolio may be fire retardant.

Abbott steps up where Biogen Idec wouldn't.

A paradigm shift is under way, and it's happening here.

You'll want to find out.

Come with me if you want to live.

They may not be the ones you're thinking of.

What to look at when you're looking ahead.

It's always darkest before the dawn.

And where to look for other "Black Swans."